| pubmed-article:8685633 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C0205725 | lld:lifeskim |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C0007807 | lld:lifeskim |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C0007682 | lld:lifeskim |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C0012854 | lld:lifeskim |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C0032520 | lld:lifeskim |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C0238607 | lld:lifeskim |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C0679932 | lld:lifeskim |
| pubmed-article:8685633 | lifeskim:mentions | umls-concept:C1709793 | lld:lifeskim |
| pubmed-article:8685633 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8685633 | pubmed:dateCreated | 1996-8-19 | lld:pubmed |
| pubmed-article:8685633 | pubmed:abstractText | The current study was designed to quantitate human cytomegalovirus (HCMV) DNA in cerebrospinal fluid (CSF) of persons with AIDS with specific HCMV-related CNS disease. DNA present in CSF obtained from AIDS patients was initially detected by a qualitative PCR procedure and then quantitated using a competitive PCR assay. In a group of 21 AIDS patients with HCMV-related CNS disease, 12 patients with HCMV polyradiculopathy had a mean +/- SEM of 11,982 +/- 4,480 copies/microliters in their CSF compared to 1,747 +/- 929 for 9 patients with HCMV encephalitis p = 0.017). Of the 14 patients with > 1,000 copies/microliters of HCMV DNA in CSF, 11(79%) had HCMV polyradiculopathy including all 3 with > 10,000 copies/microliters. Ganciclovir treatment of 3 patients with HCMV-related CNS disease was associated with a decline in HCMV DNA detectable within CSF. These data indicate that quantities of HCMV DNA in CSF are higher in persons with HCMV-related polyradiculopathy than encephalitis, and that quantitation of HCMV DNA can be useful in monitoring antiviral therapy. | lld:pubmed |
| pubmed-article:8685633 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8685633 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8685633 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8685633 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8685633 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8685633 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8685633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8685633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8685633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8685633 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8685633 | pubmed:issn | 0036-5548 | lld:pubmed |
| pubmed-article:8685633 | pubmed:author | pubmed-author:SpectorS ASA | lld:pubmed |
| pubmed-article:8685633 | pubmed:author | pubmed-author:ShinkaiMM | lld:pubmed |
| pubmed-article:8685633 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8685633 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:8685633 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8685633 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8685633 | pubmed:pagination | 559-61 | lld:pubmed |
| pubmed-article:8685633 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:meshHeading | pubmed-meshheading:8685633-... | lld:pubmed |
| pubmed-article:8685633 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8685633 | pubmed:articleTitle | Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. | lld:pubmed |
| pubmed-article:8685633 | pubmed:affiliation | Department of Pediatrics, University of California, San Diego, La Jolla, USA. | lld:pubmed |
| pubmed-article:8685633 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8685633 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8685633 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8685633 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8685633 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8685633 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8685633 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8685633 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8685633 | lld:pubmed |
